belong to the  3 integrin subfamily. Although the  3 subunit is a key regulator for the biosynthesis of  3 integrins, it remains obscure whether missense mutations in  3 may induce the same defects in both ␣ IIb  3 and ␣ v  3 . In this study, it is revealed that thrombasthenic platelets with a His280Pro mutation in  3 , which is prevalent in Japanese patients with Glanzmann thrombasthenia, did contain significant amounts of ␣ v  3 (about 50% of control) using sensitive enzyme-linked immunosorbent assay. Expression studies showed that the His280Pro 3 mutation impaired ␣ IIb  3 expression but not ␣ v  3 expression in 293 cells. To extend these findings, the effects of several  3 missense mutations leading to an impaired ␣ IIb  3 expression on ␣ v  3 function as well as expression was examined: Leu117Trp, Ser162Leu, Arg216Gln, Cys374Tyr, and a newly created Arg216Gln/Leu292Ser mutation.
IntroductionIntegrins are a family of cell surface molecules that mediate cellular attachment to the extracellular matrix and cell cohesion and are involved in such diverse biologic processes as thrombus formation, angiogenesis, inflammation, and embryogenesis. 1 Integrins are ␣ heterodimers, and  3 is one of 8 known  subunits. ␣ IIb  3 and ␣ v  3 belong to the  3 integrin subfamily and share the same  subunit ( 3 ). 2,3 ␣ IIb  3 , whose expression is restricted to the megakaryocyte/platelet lineage, is a prototypic integrin that functions as a physiologic receptor for fibrinogen and von Willebrand factor and plays a crucial role in normal hemostasis and platelet aggregation. 4 On the other hand, ␣ v  3 is expressed in a number of tissues, such as platelets, endothelial cells, smooth muscle cells, and osteoclasts, and plays a key role in cell proliferation, cell migration, angiogenesis, and bone resorption. [5][6][7] Glanzmann thrombasthenia (GT) is a rare autosomal recessive bleeding disorder characterized by a quantitative or qualitative abnormality of ␣ IIb  3 and caused by a defect in either the ␣IIb or  3 gene. [8][9][10][11] The quantitative abnormality in GT can be divided into 2 groups: type I has a severe ␣ IIb  3 deficiency (Ͻ 5% of normal) with no or minimal clot retraction, and type II has a moderate ␣ IIb  3 deficiency (10%-20% of normal) with normal or only moderately diminished clot retraction. 8 The numbers of ␣ IIb  3 and ␣ v  3 expressed on the platelet surface are 40 000 to 80 000 molecules per platelet and about 100 molecules per platelet, respectively. 12 Previous studies have shown that ␣ IIb  3 and ␣ v  3 are synthesized by a similar mechanism. 13 The ␣IIb ␣v and  3 subunits are synthesized from separate messenger RNA transcripts, and the  3 subunit becomes associated with either pro␣IIb or pro␣v, single-chain precursor forms of ␣ subunits, in the endoplasmic reticulum. The pro␣ IIb  3 and pro␣ v  3 complex are then transported to the Golgi apparatus, where pro␣ subunits undergo sugar modification and endoproteolytic cleavage into heavy and light chains. After these process...